1 |
BLACK L M, LEVER J M, AGARWAL A. Renal inflammation and fibrosis: a double-edged sword[J]. J Histochem Cytochem, 2019, 67(9): 663-681.
|
2 |
HUMPHREYS B D. Mechanisms of renal fibrosis[J]. Annu Rev Physiol, 2018, 80: 309-326.
|
3 |
ZHOU T, LUO M C, CAI W, et al. Runt-related transcription factor 1 (RUNX1) promotes TGF-β-induced renal tubular epithelial-to-mesenchymal transition (EMT) and renal fibrosis through the PI3K subunit p110δ[J]. EBioMedicine, 2018, 31: 217-225.
|
4 |
HUANG R S, FU P, MA L. Kidney fibrosis: from mechanisms to therapeutic medicines[J]. Signal Transduct Target Ther, 2023, 8(1): 129.
|
5 |
VILAYSANE A, CHUN J, SEAMONE M E, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD[J]. J Am Soc Nephrol, 2010, 21(10): 1732-1744.
|
6 |
KE B, SHEN W, FANG X D, et al. The NLPR3 inflammasome and obesity-related kidney disease[J]. J Cell Mol Med, 2018, 22(1): 16-24.
|
7 |
阮颖新, 张鹏宇, 林 珊, 等. 内质网应激相关凋亡途径参与单侧输尿管梗阻大鼠肾间质纤维化[J]. 中华肾脏病杂志, 2011, 27(5): 357-362.
|
8 |
HORTELANO S, GONZÁLEZ-COFRADE L, CUADRADO I, et al. Current status of terpenoids as inflammasome inhibitors[J]. Biochem Pharmacol, 2020, 172: 113739.
|
9 |
ZHANG W J, LI K Y, LAN Y, et al. NLRP3 Inflammasome: a key contributor to the inflammation formation[J]. Food Chem Toxicol, 2023, 174: 113683.
|
10 |
LIN C, JIANG Z X, CAO L, et al. Role of NLRP3 inflammasome in systemic sclerosis[J]. Arthritis Res Ther, 2022, 24(1): 196.
|
11 |
POTERE N, DEL BUONO M G, CARICCHIO R, et al. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications[J]. EBioMedicine, 2022, 85: 104299.
|
12 |
ALLOATTI G, PENNA C, COMITÀ S, et al. Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease[J]. Vascul Pharmacol, 2022, 145: 107001.
|
13 |
BRAGA T T, FORESTO-NETO O, CAMARA N O S. The role of uric acid in inflammasome-mediated kidney injury[J]. Curr Opin Nephrol Hypertens, 2020, 29(4): 423-431.
|
14 |
ARANDA-RIVERA A K, SRIVASTAVA A, CRUZ-GREGORIO A, et al. Involvement of inflammasome components in kidney disease[J]. Antioxidants, 2022, 11(2): 246.
|
15 |
HUANG G Z, ZHANG Y D, ZHANG Y Y, et al. Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies[J]. Biochem Biophys Rep, 2023, 33: 101417.
|
16 |
ARANDA-RIVERA A K, CRUZ-GREGORIO A, APARICIO-TREJO O E, et al. Redox signaling pathways in unilateral ureteral obstruction (UUO)- induced renal fibrosis[J]. Free Radic Biol Med, 2021, 172: 65-81.
|
17 |
WU M, HAN W X, SONG S, et al. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice[J]. Mol Cell Endocrinol, 2018, 478: 115-125.
|
18 |
KIM Y G, KIM S M, KIM K P, et al. The role of inflammasome-dependent and inflammasome-independent NLRP3 in the kidney[J]. Cells, 2019, 8(11): 1389.
|
19 |
MISHRA S R, MAHAPATRA K K, BEHERA B P, et al. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics[J]. Int J Biochem Cell Biol, 2021, 136: 106013.
|
20 |
ZHUANG Y B, YASINTA M, HU C Y, et al. Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury[J]. Am J Physiol Renal Physiol, 2015, 308(8): F857-F866.
|
21 |
WU Y S, HE F, LI Y Q, et al. Effects of Shizhifang on NLRP3 inflammasome activation and renal tubular injury in hyperuricemic rats[J]. Evid Based Complement Alternat Med, 2017, 2017: 7674240.
|
22 |
FENG H, GU J L, GOU F, et al. High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells[J]. J Diabetes Res, 2016, 2016: 6973175.
|
23 |
LIU H X, ZHAO L, YUE L, et al. Pterostilbene attenuates early brain injury following subarachnoid hemorrhage via inhibition of the NLRP3 inflammasome and Nox2-related oxidative stress[J]. Mol Neurobiol, 2017, 54(8): 5928-5940.
|
24 |
梁文杰, 毕建成, 许庆友. NLRP3炎症小体在慢性肾脏病的表达及中药的干预机制[J]. 中药药理与临床, 2016, 32(3): 208-211.
|
25 |
ANDERS H J, SUAREZ-ALVAREZ B, GRIGORESCU M, et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury[J]. Kidney Int, 2018, 93(3): 656-669.
|
26 |
WANG W J, WANG X Y, CHUN J, et al. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium[J]. J Immunol, 2013, 190(3): 1239-1249.
|
27 |
BRACEY N A, GERSHKOVICH B, CHUN J, et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome[J]. J Biol Chem, 2014, 289(28): 19571-19584.
|